Raphael Pharmaceutical (RAPH) Share-based Compensation Growth (3y) (2025)

Raphael Pharmaceutical (RAPH) Share-based Compensation Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.35%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 24.36%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.84%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 88.54%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 23.49%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 11.76%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 20.51%
10 Raphael Pharmaceutical 27.37 Mn 27.33 Mn - 26.01%

Historic Data

Download Data
DateValue
Dec 31, 2025 26.01%
Sep 30, 2025 -68.09%
Jun 30, 2025 -61.48%
Mar 31, 2025 9.51%